NovaBridge Biosciences

NASDAQ:NBP

Biotechnology

Healthcare
$0.90 -4.78%

-$0.07 today

Market cap
$104.10M
Beta
1.48
P/E (TTM)
-25.5
EPS (TTM)
-$0.40
52W Low $1.46High $6.79

Volume 0.87M

Average 0.90M

NBP Other Non-current Liabilities

Long-term obligations not reported separately, such as lease or pension liabilities.

NovaBridge BiosciencesNASDAQ: NBP

Other Non-current Liabilities · Q4 FY2025 · quarter ended Dec 2025

Other non-current liabilities rises 13948.5% from a year ago

Other non-current liabilities stood at $73.05K at the end of Q4 FY2025, up 13948.5% from a year earlier and up 676.1% from the prior quarter. Over 3 fiscal years it compounded at -94.2% a year.

Context

  • Other non-current liabilities amounted to 0.2% of total assets at the end of Q4 FY2025, up 0.2 pp from a year earlier.
  • Other non-current liabilities increased in 1 of the last 3 fiscal years.

What to watch

Whether other non-current liabilities keeps rising in the next quarterly balance sheet after a +13948.5% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterDec 2025
$73.05K+676.1% QoQ
Last fiscal yearDec 2025
$73.05K+1825.0% YoY
Year agoDec 2024
$520+13948.5% since
Other Non-current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+13948.5%——
1 year+1825.0%——
3-year CAGR-94.2%——
5-year CAGR——
10-year CAGR——

Other Non-current Liabilities history

Mixed currencies · from the balance sheet

Latest · FY2025
73.05K USD
Year-over-year change
—

Other Non-current Liabilities vs competitors

How NBP compares with its peers on the latest reported figures

  • NBP's Dec 2025 other non-current liabilities of $73.05K is the 7th highest of the 11 companies compared; the peer median is $1.1M.
  • Its year-over-year change of +13948.5% is the highest of 6, against a peer median of +15.9%.
  • Other non-current liabilities amounts to 0.2% of total assets for NBP, versus a peer median of 0.3%.
NBP Competitors Peer median
Other Non-current Liabilities for NBP and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ENGNenGene Holdings Inc.Apr 2026$24.91M ——8.1%
DRTSAlpha Tau Medical Ltd.Mar 2026$15.75M +344.2%-1.7%14.5%
ALTAltimmune, Inc.Mar 2026$4.59M +15.9%+4.4%1.4%
GALTGalectin Therapeutics Inc.Mar 2026$2.98M +2090.4%+83.7%18.9%
LBRXLB Pharmaceuticals Inc Common StockMar 2026$1.14M -40.6%-62.6%0.3%
RCKTRocket Pharmaceuticals, Inc.Mar 2026$1.06M -6.9%-25.8%0.4%
NBPNovaBridge BiosciencesDec 2025$73.05K +13948.5%-94.2%0.2%
AURAAura Biosciences, Inc.Mar 2026$0 ——0.0%
DSGNDesign Therapeutics, Inc.Mar 2026$0 ——0.0%
ANNXAnnexon, Inc.Mar 2026$0 ——0.0%
DMACDiaMedica Therapeutics Inc.Mar 2026$0 ——0.0%
Peer median (excluding NBP) $1.1M+15.9%-1.7%0.3%

Competitors are the stored peer set for NBP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

Mixed currencies
Metric
FY2021
Dec 2021 · CNY
FY2022
Dec 2022 · CNY
FY2023
Dec 2023 · CNY
FY2024
Dec 2024 · CNY
FY2025
Dec 2025 · USD
Cash & Equivalents552.8M3.21B291.51M498.24M30.11M
Short-term Investments118.16M235.43M20.22M767.36M30.02K
Net Receivables60.95M4.81M1.83M8.55M256.33K
Inventory4.27M(80.28M)000
Other Current Assets0242.96M15.68M10
Total Current Assets750.18M3.63B329.91M1.29B31.1M
Property, Plant & Equipment (Net)24.87M123.97M5.55M27.72M421.59K
Goodwill25.51M162.57M000
Intangible Assets18.77M118.89M000
Long-term Investments55.24M30.85M0224.98M5.32M
Tax Assets00000
Other Non-current Assets4.18M10.91M33.46M9.96M402K
Total Non-current Assets128.56M447.19M39.01M262.66M6.15M
Total Assets878.74M4.07B368.92M1.55B37.24M
Account Payables00000
Short-term Debt02.75M000
Tax Payables00000
Deferred Revenue371.66K2.19M0773.67K0
Other Current Liabilities0549.85M49.67M5.01M1.31M
Total Current Liabilities97.9M659.74M58.14M61.7M3.84M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)37.49M0106K00
Other Non-current Liabilities15.2M373.53M64.83M3.8K73.05K
Total Non-current Liabilities65.52M405.6M68.19M22.38M384.13K
Total Liabilities163.42M1.07B126.34M84.08M4.23M
Common Stock19.77K132K19K138.68K3.86K
Retained Earnings(683.21M)(6.77B)(1.26B)(9.39B)(190.47M)
Accumulated OCI(29.26M)216.72M39.77M243.66M5.94M
Other Stockholders Equity00000
Minority Interest00000
Total Equity715.33M3.01B242.58M1.47B33.02M
Total Debt17.64M38.29M3.89M28.33M438.46K
Net Debt(535.16M)(3.18B)(287.62M)(469.9M)(29.67M)

NovaBridge Biosciences

NASDAQ:NBP

Intrinsic Alpha fair value

Locked

Current Price

$0.90

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.